Related Party Transactions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2022 | |||
Related Party Transactions [Abstract] | |||
Related Party Transactions |
Pre-Merger
Financing and Waiver Agreements
Five directors of Ocuphire Pharma, Inc., prior to the Merger, and one
director of Rexahn participated in the Pre-Merger Financing, investing an aggregate of $300,000. Following the closing of the
Merger, these directors received 17,729 converted initial shares of common stock, 53,189 converted shares of additional common stock, 80,366
Series A Warrants and 9,444 Series B Warrants. In connection with the Pre-Merger Financing, six directors of the Company signed Waiver Agreements, waiving certain reset provisions and financing restrictions. These directors did not
receive any of the additional Series B Warrants that were issued in connection with the Waiver Agreements. See Note 3 – Pre-Merger Financing.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|